$A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors$

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

Bibliographic Details
Main Authors:	Candelaria Myrna, Gallardo-Rincón Dolores, Arce Claudia, Cetina Lucely, Aguilar-Ponce Jose, Arrieta Oscar, Serrano Alberto, Perez-Plasencia Carlos, Gonzalez-Fierro Aurora, de la Cruz-Hernandez Erik, Revilla-Vazquez Alma, Chavez-Blanco Alma, Trejo-Becerril Catalina, Perez-Cardenas Enrique, Taja-Chayeb Lucia, Camargo Maria F, Robles Elizabeth, Dueñas-Gonzalez Alfonso
Format:	Article
Language:	English
Published:	BMC 2007-02-01
Series:	BMC Cancer

Similar Items